Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 21, 2022

BUY
$2.19 - $3.98 $25,185 - $45,770
11,500 New
11,500 $28,000
Q1 2022

Apr 19, 2022

SELL
$3.28 - $7.12 $44,608 - $96,832
-13,600 Closed
0 $0
Q4 2021

Jan 13, 2022

SELL
$6.55 - $13.25 $78,600 - $159,000
-12,000 Reduced 46.88%
13,600 $90,000
Q3 2021

Oct 08, 2021

SELL
$7.29 - $11.0 $729 - $1,100
-100 Reduced 0.39%
25,600 $231,000
Q2 2021

Jul 27, 2021

BUY
$9.87 - $13.32 $253,658 - $342,324
25,700 New
25,700 $300,000

Others Institutions Holding ME

About 23andMe Holding Co.


  • Ticker ME
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 259,768,000
  • Market Cap $823M
  • Description
  • 23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of pa...
More about ME
Track This Portfolio

Track Wedbush Securities Inc Portfolio

Follow Wedbush Securities Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wedbush Securities Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wedbush Securities Inc with notifications on news.